Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial

Aging and Cognitive FunctionsMultiple Sclerosis
Do you want to read an article? Please log in or register.